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Web Appendix Table 1. Comparative descriptive statistics of China, Ghana, India, Mexico, Russia, and South Africa, 2008 
 Lower and Lower Middle Income Upper Middle and Upper Income  
 
Ghana India China South Africa Mexico Russia 
GDP per capita, PPP (constant 2011 international $) 2,865 3,980 7,732 11,741 15,704 22,558 
Mortality rate, infant (per 1,000 live births) 54 51 16 45 15 12 
Life expectancy at birth, total (years) 60 65 75 53 76 68 
Health expenditure per capita, PPP (constant 2005 
international $) 
84 114 282 814 892 1030 
Health expenditure, public (% of total health expenditure) 58 26.3 49.9 45.8 47 66.5 
Out-of-pocket health expenditure (% of total expenditure on 
health) 
28.4 64.2 40 8.5 49.2 27.3 
Physicians (per 1,000 people) 0.1 0.6
 
1.7 0.8
  
2.9
  
4.3
  
Hospital beds (per 1,000 people) 0.9
  
0.9
  
2.2
  
2.8
  
1.6 9.7
  
Geographic Region Sub-Saharan 
Africa 
South Asia East Asia & 
Pacific 
Sub-Saharan 
Africa 
Latin America & 
Caribbean 
Europe and 
Central Asia 
Sources: World Bank http://data.worldbank.org/ ; WHO Health Statistics http://www.who.int/gho/publications/world_health_statistics/en/index.html 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Web Appendix Table 2: Description of the methods of both self-reported diagnoses and symptoms-based/criterion-based measures for specific 
NCDs 
NCDs Self-reported diagnoses  Symptoms-based/criterion-based measures 
Angina Have you ever been diagnosed 
with angina or angina pectoris (a 
heart disease)? 
Each of the following 3 conditions were to be met:  
1) During the last 12 months, the respondents have had experienced any pain or discomfort in the chest 
when walking uphill or hurry and/or ordinary pace on level ground.  
2) The pain or discomfort had been relieved while just simply stopping the walk. 
3) The pain or discomfort site is either ‘sternum’ (all level) or ‘left anterior chest and left arm’. 
To identify location of pain or discomfort, respondents were asked to choose from a picture depicting 
numbered panels of the upper body.  
 
Hypertension Have you ever been diagnosed 
with high blood pressure 
(hypertension)? 
Blood pressure measurement were taken with ‘Boso Medistar Wrist Blood Pressure Monitor Model S’ 
where the systolic blood pressure, diastolic blood pressure and pulse rate were documented. Blood 
pressure measurements were done three times for each respondent and at least 1 minute interval has been 
given between each blood pressure reading. Based on the WHO criteria of hypertension for adults 18 
years and older, we defined people with hypertension as those who have reported the systolic blood 
pressure ≥140 mmHg and/or diastolic blood pressure ≥90 mmHg. S there were  three blood pressure 
readings, we have taken an average of the three readings, separately for systolic blood pressure and 
diastolic blood pressure (22, 23).  
 
Asthma & 
Chronic lung 
diseases 
Have you ever been diagnosed 
with asthma (an allergic respiratory 
disease)? 
Have you ever been diagnosed 
with chronic lung disease 
(emphysema, bronchitis, COPD)? 
Spirometry was performed after the administration of an adequate dose of short-acting inhaled 
bronchodilator in order to minimise variability. The respondents were asked to take a deep breath and 
then to blow as long and hard as he/she can into a small tube attached to the spirometer machine and then 
FEV1 (Forced Expiratory Volume in One Second) and FVC (Forced Vital Capacity) were documented. 
Three trails of spirometry test were performed. The ratio of FEV1 (Forced Expiratory Volume in One 
Second) to FVC (Forced Vital Capacity) was calculated. Following the specific spirometry cut-points 
suggested by GOLD,  those with FEV1/FVC  <70% and also had an  FEV1 < ‘80% predicted’, in all the 
three trials, were termed as people with moderate and above forms of (including severe and very severe) 
obstructive (lung) diseases (24).  
 
Visual 
impairment 
In the last 5 years, were you 
diagnosed with a cataract in one or 
both of your eyes (cloudiness in 
the lens of the eye)? 
Using the four meter distance vision Tumbling E LogMAR chart, vision tests were conducted for 
distance vision for both left and right eyes and the recorded the resulting ‘DECIMAL’ value of each eye. 
If the respondents use the glasses or contact lenses, the tests were conducted using them. In accordance 
with WHO criteria (25, 26), we applied the definition of the low vision as an approximate Log MAR 
equivalent of ‘0.5 and above’ which corresponded to  a ‘DECIMAL’ value  of ‘0.32 and below’, thus, in 
our analysis, those who score ‘DECIMAL’ value of ‘0.32 and below’ in the distance vision test for at 
least one eye were categorized as suffering from visual impairment. 
 
Depression Have you ever been diagnosed 
with depression? 
In order to categorize a person as suffering from ‘moderate depression’, firstly, the following two 
‘General criteria’ (i.e., General criteria 1 and 2) should be met(27).  
1) General criteria 1: At least two of the following three symptoms (conditions) must be present: i) 
during the last 12 months, have had a period lasting several days when felt sad, empty or depressed; ii) 
during the last 12 months, have had a period lasting several days when lost interest in most things usually 
enjoy such as personal relationships, work or hobbies/recreation, iii) during the last 12 months, have had 
a period lasting several days when have been feeling energy decreased or that are tired all the time.  
2) General criteria 2: The depressive episode should last for at least 2 weeks.  
Secondly, if the above stated conditions are met, then a total of at least six conditions (symptoms) should 
be present to term a person as having ‘moderate depression’. These six conditions can be  from the above 
stated three conditions from ‘General criteria 1’, and/or, from the following ‘Seven Sub-conditions’  
3) Seven Sub-conditions 
i) During this period, person did feel negative about him/herself or like he/she had lost confidence and/or 
did frequently feel hopeless - that there was no way to improve things,  
ii) During this period, person did feel anxious and worried most days,  
iii) During this period, the person did think of death, or wish he/she were dead, and/or  did he/she ever 
try to end own life,  
iv) During this period, did he/she have any difficulties concentrating; for example, listening to others, 
working, watching TV, listening to the radio, and/or did notice any slowing down in his/her thinking,  
v) He/she did notice any slowing down in his/her moving around, and/or he/she were so restless or jittery 
nearly every day that he/she paced up and down and couldn’t sit still,  
vi) He/she did notice any problems falling asleep, and/or, he/she did notice any problems waking up too 
early, and  
vii) During this period, he/she did lose his/her appetite. 
Source: author’s compilation from various sources 
 
 
 
 
Web Appendix Table 3: Age-adjusted prevalence rate (in %, with 95% CI) of NCDs across wealth quintiles, measured through self-reported 
diagnoses and symptoms-based/criterion-based measure, among adult population in China, Ghana, India, Mexico, Russia, and South Africa 
 Angina Hypertension Asthma and chronic lung 
diseases 
Visual impairment Depression 
 Symptoms-
based measure 
Self-reported 
diagnoses 
Criterion-based 
measure 
Self-reported 
diagnoses 
Criterion-based 
measure 
Self-reported 
diagnoses 
Criterion-based 
measure 
Self-reported 
diagnoses 
Symptoms-
based measure 
Self-reported 
diagnoses 
Ghana           
Lowest quintile 4.4[2.5;6.3] 1.7[0.2;3.2] 34.8[29.7;39.9] 2.5[1.3;3.7] 0.9[0.0;1.8] 1.9[0.3;3.6] 13.2[10.3;16.1] 1.4[0.4;2.4] 4.3[2.1;6.5] 0.2[0.1;0.4] 
2nd 4.9[3.1;6.7] 0.8[0.4;1.1] 41.9[36.3;47.6] 4.0[2.8;5.2] 2.8[0.9;4.8] 4.7[2.1;7.2] 18.7[14.8;22.6] 1.6[0.8;2.3] 5.2[3.2;7.3] 0.6[0.3;0.8] 
3rd 4.7[2.9;6.4] 1.2[0.4;2.1] 47.1[41.8;52.3] 8.5[5.3;11.6] 0.9[0.0;1.8] 1.3[0.8;1.9] 11.4[8.6;14.2] 1.4[0.6;2.1] 3.9[1.8;5.9] 1.0[0.2;1.7] 
4th 3.0[1.1;4.9] 2.9[1.1;4.6] 46.3[40.8;51.7] 10.0[7.2;12.9] 2.2[0.4;3.9] 2.2[0.7;3.6] 10.4[7.1;13.8] 2.7[1.7;3.6] 2.8[1.2;4.4] 0.6[0.2;0.9] 
Highest quintile 1.7[0.6;2.9] 1.1[0.6;1.5] 40.8[35.0;46.5] 13.9[10.4;17.4] 1.0[0.5;1.5] 1.6[0.8;2.4] 15.5[11.6;19.3] 3.9[2.4;5.3] 6.1[3.1;9.1] 1.1[-0.2;2.3] 
India           
Lowest quintile 10.7[8.7;12.7] 3.0[2.0;4.0] 18.4[15.8;21.0] 5.3[3.9;6.6] 5.3[3.9;6.7] 7.5[5.7;9.3] 19.5[17.2;21.7] 5.1[4.1;6.1] 10.1[8.3;12.0] 2.4[1.4;3.3] 
2nd 7.6[5.9;9.2] 2.4[1.5;3.3] 17.5[15.2;19.9] 6.7[5.4;8.1] 5.7[4.4;7.0] 5.0[3.7;6.3] 17.6[15.6;19.7] 5.9[4.8;7.1] 9.5[7.9;11.2] 3.0[1.8;4.2] 
3rd 7.0[5.5;8.5] 3.9[2.6;5.2] 18.8[16.5;21.2] 9.8[7.9;11.7] 4.9[3.5;6.2] 5.9[4.3;7.4] 17.2[15.3;19.2] 6.0[4.9;7.2] 10.3[8.5;12.0] 4.3[2.9;5.7] 
4th 6.3[4.7;7.9] 3.0[2.0;4.0] 19.7[17.2;22.1] 9.7[8.1;11.3] 5.0[3.7;6.3] 5.2[3.7;6.7] 17.3[15.3;19.3] 6.5[5.2;7.7] 6.8[5.3;8.2] 4.8[3.4;6.2] 
Highest quintile 3.4[2.4;4.4] 2.7[1.9;3.4] 21.3[18.5;24.2] 15.2[13.0;17.4] 5.0[3.7;6.3] 5.6[3.7;7.5] 12.4[10.9;13.9] 6.6[5.5;7.7] 5.6[4.1;7.0] 2.9[1.8;3.9] 
China           
Lowest quintile 1.7[0.9;2.5] 3.0[2.1;3.9] 38.6[35.1;42.2] 9.6[7.7;11.4] 1.5[1.0;1.9] 4.1[3.0;5.2] 16.0[13.3;18.6] 2.9[1.5;4.2] 1.2[0.6;1.8] 0.1[0.0;0.1] 
2nd 1.4[0.7;2.2] 3.9[2.9;5.0] 37.9[34.0;41.8] 9.0[7.3;10.8] 1.1[0.8;1.5] 4.1[2.9;5.3] 12.6[10.2;15.0] 2.3[1.8;2.7] 1.7[0.3;3.0] 0.1[0.0;0.1] 
3rd 1.9[0.6;3.3] 3.0[2.2;3.9] 40.5[35.8;45.1] 12.6[9.9;15.4] 1.1[0.6;1.5] 5.3[3.1;7.5] 14.4[11.5;17.3] 2.6[2.1;3.1] 0.4[-0.1;1.0] 1.1[-0.2;2.4] 
4th 0.8[0.4;1.2] 4.3[2.6;6.1] 35.8[31.3;40.2] 14.1[11.1;17.1] 1.3[0.3;2.2] 3.6[2.5;4.8] 14.0[11.2;16.8] 2.7[2.3;3.2] 1.2[0.1;2.3] 0.2[0.0;0.4] 
Highest quintile 1.0[0.3;1.8] 4.3[2.4;6.1] 34.6[29.9;39.3] 13.6[11.0;16.2] 1.4[0.6;2.1] 3.3[2.2; 4.4] 15.5[12.1;18.9] 3.9[2.6;5.2] 0.4[-0.2;0.9] 0.4[-0.2;0.9] 
South Africa          
Lowest quintile 1.0[0.4;1.6] 1.0[0.4;1.6] 45.0[38.7;51.2] 5.9[4.9;6.9] 0.7[0.4;1.0] 4.2[0.9;7.5] 20.0[15.4;24.6] 3.2[0.8;5.6] 6.2[2.3;10.2] 0.6[0.1;1.2] 
2nd 1.5[0.8;2.2] 1.1[0.6;1.5] 57.2[51.0;63.4] 8.7[6.7;10.7] 1.2[0.5;1.9] 2.3[1.3;3.4] 20.1[15.4;24.7] 0.8[0.5;1.2] 4.3[0.0;8.6] 4.4[0.1;8.6] 
3rd 1.7[0.5;2.8] 3.2[1.3;5.1] 59.4[54.8;64.0] 15.2[10.8;19.7] 6.2[2.4;10.1] 2.8[1.4;4.3] 13.7[11.8;15.7] 3.8[2.7;5.0] 3.9[1.0;6.7] 5.8[3.1;8.4] 
4th 5.1[4.0;6.1] 3.1[2.1;4.2] 51.0[45.6;56.3] 13.4[10.8;16.0] 0.5[0.1;10.9] 5.2[3.1;7.3] 18.9[15.0;22.8] 1.2[0.7;1.6] 5.6[3.6;7.5] 5.5[3.4;7.6] 
Highest quintile 0.5[0.1;1.0] 10.7[8.7;12.8] 53.0[47.6;58.4] 12.0[9.2;14.8] 0.4[0.0;0.8] 2.7[0.8;4.6] 25.7[20.9;30.6] 3.5[1.4;5.5] 1.2[0.8;1.6] 5.4[2.5;8.4] 
Mexico           
Lowest quintile 10.8[7.8;13.9] 0.7[0.5;0.9] 25.4[21.8;29.1] 11.9[9.2;14.6] 0.2[0.0;0.4] 5.0[3.6;6.3] 30.5[23.9;37.1] 12.7[7.0;18.3] 7.5[5.8;9.2] 12.2[9.6;14.8] 
2nd 8.3[6.0;10.5] 0.6[0.3;0.9] 28.2[22.1;34.3] 8.5[6.9;10.2] 0.3[-0.4;1.1] 10.9[7.5;14.3] 17.7[14.4;21.1] 2.9[2.2;3.7] 1.8[0.6;3.0] 7.5[4.7;10.2] 
3rd 6.5[3.3;9.8] 0.6[0.2;1.0] 32.6[27.5;37.6] 11.6[9.1;14.1] 0.3[0.1;0.5] 2.7[1.3;4.2] 22.0[18.3;25.8] 4.3[2.9;5.7] 10.1[6.9;13.4] 13.5[9.5;17.4] 
4th 7.4[5.5;9.4] 1.7[-0.1;3.5] 31.2[25.0;37.4] 22.1[17.6;26.6] 0.1[-0.1;0.4] 5.5[1.6;9.3] 27.8[22.0;33.6] 3.4[2.4;4.4] 8.2[3.8;12.6] 12.3[8.0;16.6] 
Highest quintile 4.0[1.5;6.5] 1.2[0.1;2.2] 29.8[23.0;36.5] 14.1[10.3;17.8] 4.0[-0.7;8.6] 3.9[1.0;6.9] 17.1[14.2;20.0] 3.7[1.6;5.8] 6.5[3.3;9.6] 8.3[4.6;11.9] 
Russia           
Lowest quintile 13.2[10.7;15.7] 18.4[15.3;21.4] 45.5[41.7;49.4] 33.8[29.9;37.8] 0.5[0.2;0.8] 11.2[8.9;13.5] 19.4[16.4;22.3] 10.6[8.1;13.0] 3.7[2.6;4.9] 3.1[1.7;4.5] 
2nd 18.9[15.6;22.1] 27.8[24.2;31.4] 41.6[38.1;45.1] 39.3[35.7;42.9] 0.2[0.0;0.5] 17.8[14.5;21.1] 26.8[23.3;30.2] 9.7[7.6;11.7] 4.8[2.4;7.2] 2.3[1.3;3.3] 
3rd 18.4[14.5;22.2] 28.4[24.1;32.7] 46.5[42.2;50.8] 41.3[36.5;46.1] 0.1[0.0;0.1] 17.0[13.8;20.2] 26.5[22.7;30.4] 10.2[7.6;12.7] 4.3[2.0;6.6] 5.0[2.6;7.4] 
4th 13.9[10.8;17.1] 23.2[19.2;27.3] 43.6[39.5;47.8] 35.5[31.7;39.3] 0.9[0.1;1.7] 15.6[12.1;19.2] 21.8[17.9;25.8] 9.7[7.3;12.0] 5.8[3.6;8.1] 3.7[1.6;5.7] 
Highest quintile 13.8[10.5;17.0] 21.3[17.1;25.4] 35.2[30.4;40.0] 39.7[35.3;44.1] 1.0[-0.1;2.0] 17.5[13.9;21.0] 20.1[17.2;23.0] 8.8[6.6;11.0] 2.6[1.0;4.2] 3.8[1.6;6.0] 
All Sample 15.7[13.5;17.9] 23.8[21.2;26.3] 41.9[39.1;44.6] 36.7[33.9;39.4] 0.3[0.1;0.4] 15.0[12.8;17.2] 24.3[21.9;26.8] 9.6[8.1;11.2] 4.8[3.3;6.3] 3.9[2.4;5.3] 
Source: WHO SAGE survey, 2007-10 
Web Appendix Table 4: Age-adjusted prevalence rate (in %, with 95% CI) of NCDs across educational level, measured through self-reported 
diagnoses and symptoms-based/criterion-based measures, among adult population in China, Ghana, India, Mexico, Russia, and South Africa 
 Angina Hypertension 
Asthma and chronic lung 
diseases Visual impairment Depression 
 
Symptoms-
based measure 
Self-reported 
diagnoses 
Criterion-based 
measure 
Self-reported 
diagnoses 
Criterion-
based 
measure 
Self-reported 
diagnoses 
Criterion-based 
measure 
Self-reported 
diagnoses 
Symptoms-
based measure 
Self-reported 
diagnoses 
Ghana           
No Formal 
Schooling 6.2[4.0;8.4] 2.0[0.6;3.5] 42.2[37.0;47.3] 4.7[2.5;6.9] 1.7[0.6;2.8] 2.5[1.9;3.1] 17.2[13.8;20.7] 1.4[0.9;2.0] 4.1[2.4;5.9] 0.3[0.2;0.5] 
Less than primary 
school 4.1[2.4;5.9] 0.9[0.2;1.5] 39.8[33.9;45.7] 6.2[3.4;9.1] 3.4[0.5;6.3] 3.8[2.0;5.7] 14.6[10.6;18.6] 1.8[1.1;2.4] 3.4[1.8;5.0] 1.0[0.5;1.5] 
Primary school 
completed 3.9[2.1;5.7] 0.9[0.5;1.4] 47.9[42.2;53.5] 10.1[6.4;13.8] 1.5[-0.2;3.2] 2.8[0.7;5.0] 13.6[10.2;17.0] 1.8[1.3; 2.4] 3.6[1.5;5.7] 0.9[0.2;1.7] 
Secondary high 
school completed 1.4[0.7;2.2] 1.7[0.7;2.7] 42.9[38.4;47.4] 9.7[7.4;12.0] 1.5[0.5;2.6] 2.8[1.6;4.0] 12.1[9.4;14.8] 3.8[2.3;5.3] 4.1[2.4;5.7] 0.2[0.0;0.3] 
College completed 
or above 1.4[0.6;2.2] 1.1[0.2;2.0] 35.8[31.4;40.2] 14.3[10.3;18.2] 0.8[0.1;1.6] 1.3[0.7;1.9] 11.6[10.3;13.0] 3.0[1.1;5.0] 4.0[1.2;6.7] 5.3[4.9;5.7] 
India 
          No Formal 
Schooling 8.5[7.2;9.8] 2.7[1.9;3.4] 19.3[17.2;21.3] 8.6[7.4;9.8] 6.3[5.0;7.5] 5.1[4.2;6.0] 18.0[16.7;19.3] 5.7[5.0;6.4] 10.5[9.1;11.9] 2.6[1.9;3.3] 
Less than primary 
school 8.1[6.0;10.1] 3.6[2.3;4.9] 18.7[15.3;22.0] 7.9[6.0;9.7] 2.8[1.9;3.7] 6.6[4.5;8.7] 17.3[14.5;20.1] 6.9[5.4;8.4] 8.3[6.2;10.3] 3.7[2.1;5.2] 
Primary school 
completed 6.5[4.8;8.1] 2.9[2.0;3.8] 21.6[18.8;24.4] 8.0[6.5;9.4] 4.9[3.6; 6.2] 5.3[3.8;6.8] 17.9[15.5;20.4] 4.8[3.9;5.7] 7.1[5.4;8.9] 3.0[1.9;4.1] 
Secondary high 
school completed 5.1[3.7;6.4] 3.8[2.7;4.9] 17.7[15.5;19.9] 12.0[10.1;13.9] 5.3[4.0;6.6] 6.5[4.8;8.1] 14.0[12.3;15.7] 7.3[6.0;8.7] 6.4[5.0;7.8] 3.3[2.3;4.3] 
College completed 
or above 2.3[0.6;4.1] 2.9[1.3;4.5] 19.8[16.0;23.5] 14.4[11.5;17.3] 3.7[2.2;5.3] 4.7[2.4;7.1] 10.9[8.4;13.3] 5.0[3.4;6.6] 4.8[1.8;7.8] 3.9[2.1;5.7] 
China 
          No Formal 
Schooling 1.1[0.8;1.3] 2.2[1.8;2.5] 51.3[45.3;57.4] 14.4[10.7;18.2] 1.3[1.0;1.5] 2.7[2.3;3.0] 17.1[13.2;21.1] 2.2[1.9;2.5] 0.8[0.2;1.4] 0.1[0.0;0.2] 
Less than primary 
school 0.5[0.3;0.7] 1.8[1.2;2.4] 34.9[29.9;40.0] 12.4[8.7;16.1] 1.5[0.5;2.5] 5.1[2.3;7.9] 16.3[12.6;20.0] 3.0[1.7;4.3] 0.7[-0.2;1.6] 0.7[-0.4;1.9] 
Primary school 
completed 1.3[0.3;2.2] 4.4[2.4;6.5] 42.1[37.4;46.9] 10.9[8.1;13.7] 0.8[0.6;1.1] 6.8[4.1;9.5] 11.4[9.1;13.8] 2.9[1.3;4.5] 0.4[0.1;0.8] 0.3[-0.2;0.8] 
Secondary high 
school completed 1.6[1.0; 2.2] 4.5[3.6;5.4] 36.7[34.2;39.3] 12.3[11.0;13.7] 1.1[0.6;1.6] 3.5[2.8;4.2] 13.4[11.6;15.2] 3.0[2.5;3.5] 1.3[0.6;1.9] 0.3[0.0;0.7] 
College completed 
or above 0.8[0.4;1.2] 3.4[2.2;4.6] 32.3[27.0;37.6] 12.4[9.2;15.6] 1.4[0.2;2.6] 6.9[3.5;10.3] 14.9[10.6;19.2] 3.3[2.6;4.0] 0.6[-0.3;1.6] 0.1[-0.1;0.2] 
South Africa 
          No Formal 
Schooling 2.6[1.7;3.6] 1.6[0.9;2.2] 65.4[57.3;73.5] 12.5[10.9;14.1] 1.4[0.0;2.7] 2.6[1.7;3.5] 17.6[12.7;22.5] 4.7[1.6;7.8] 3.7[0.0;7.4] 0.7[0.3;1.2] 
Less than primary 
school 2.6[0.6;4.6] 2.6[0.6;4.6] 57.0[50.6;63.5] 17.6[12.3;23.0] 3.7[-1.0;8.3] 6.9[1.9;11.9] 16.9[13.2;20.7] 1.1[0.6;1.5] 3.2[0.3;6.0] 1.8[-0.2;3.7] 
Primary school 
completed 4.5[4.0;4.9] 7.7[5.8;9.7] 54.6[49.4;59.8] 12.0[8.9;15.1] 1.2[0.5;1.9] 6.1[3.2;8.9] 17.8[14.6;20.9] 1.7[1.2;2.3] 4.3[1.6;6.9] 3.6[1.2;6.0] 
Secondary high 
school completed 0.7[0.2;1.2] 2.9[1.4;4.4] 47.8[41.5;54.1] 10.8[8.4;13.2] 0.3[0.0;0.6] 3.2[1.6;4.9] 22.6[17.6;27.6] 3.8[1.4;6.2] 4.1[0.7;7.6] 6.0[2.1;9.9] 
College completed 
or above 1.2[-0.2;2.6] 4.5[3.1;5.8] 60.5[57.6;63.3] 10.2[6.3;14.2] 0.2[-0.1;0.4] 0.6[-0.1;1.3] 23.5[20.8;26.1] 1.8[1.1;2.5] 0.3[0.0;0.6] 9.0[7.8;10.3] 
Mexico 
          No Formal 
Schooling 
ǂ ǂ ǂ ǂ ǂ ǂ ǂ ǂ ǂ ǂ 
Less than primary 
school 6.6[3.9;9.4] 1.9[0.0;3.9] 24.7[21.6;27.8] 13.0[10.4;15.7] 0.2[0.0;0.3] 2.0[0.9;3.0] 25.8[22.9;28.7] 4.3[2.9;5.6] 3.2[1.9;4.5] 7.5[5.7;9.4] 
Primary school 
completed 7.9[4.9;10.8] 4.2[2.1;6.3] 29.5[24.1;34.9] 16.5[12.9;20.0] 1.5[-1.3;4.2] 9.2[4.8;13.7] 24.9[20.6;29.1] 3.3[2.3;4.4] 4.6[2.2;7.0] 12.0[8.4;15.7] 
Secondary high 
school completed 6.3[3.2;9.3] 1.0[0.6;1.5] 28.7[23.4;34.0] 11.7[9.0;14.4] 0.9[-0.8;2.5] 3.5[1.6;5.4] 25.2[20.4;30.0] 2.8[1.5;4.0] 7.2[4.1;10.4] 10.0[6.8;13.3] 
College completed 
or above 2.1[0.3;3.9] 0.2[0.0;0.4] 26.6[22.8;30.5] 15.8[12.5;19.1] 0.6[0.1;1.1] 3.9[2.0;5.8] 16.2[13.8;18.6] 8.8[7.2;10.5] 9.6[6.4;12.9] 12.8[8.9;16.7] 
Russia 
          No Formal 
Schooling 32.4[28.2;36.5] 29.3[25.1;33.5] 67.6[63.5;71.8] 79.2[75.8; 82.6] 0.0[0.0;0.0] 16.1[12.5;19.6] 43.2[39.8;46.7] 24.3[20.4;28.3] 12.3[9.7;14.9] 0.0[0.0;0.0] 
Less than primary 
school 30.6[24.4;36.7] 31.5[24.9;38.2] 68.4[62.4;74.5] 73.6[68.8;78.4] 3.8[0.0;0.0] 29.1[22.7;35.5] 40.4[35.7;45.0] 16.5[12.4;20.7] 13.9[11.3;16.4] 2.7[0.0;5.4] 
Primary school 
completed 32.0[25.8;38.2] 35.0[30.0; 40.1] 64.9[58.9;71.0] 53.3[47.1;59.6] 2.6[0.8;4.3] 26.9[21.3;32.5] 37.0[31.4;42.7] 12.3[8.8;15.9] 3.1[0.8;5.4] 1.0[0.0;1.9] 
Secondary high 
school completed 15.8[13.1;18.4] 24.0[21.2;26.9] 44.5[41.4;47.7] 39.5[36.4; 42.6] 0.5[0.2;0.8] 16.4[13.8;19.1] 25.1[22.3;27.8] 9.4[7.5;11.3] 4.8[3.1;6.5] 4.3[2.5;6.1] 
College completed 
or above 13.5[10.7;16.3] 22.8[20.2;25.5] 33.3[29.9;36.7] 31.5[28.2;34.9] 0.0[0.0;0.1] 9.7[7.4;12.0] 17.3[13.9;20.6] 13.2[10.3;16.1] 3.8[1.8;5.9] 4.7[2.6; 6.8] 
Notes:Source: WHO SAGE survey, 2007-10. ǂ  no observations were reported in the survey corresponding to ‘No Formal schooling’ in the sample in Mexico.  
 
 
 
Web Appendix Table 5: Unadjusted and Adjusted Odds Ratio (with 95% CI) of self-reported diagnoses and symptoms-based/criterion-based 
measures of NCDs among adult population in China, Ghana, and India. 
 Ghana India China 
Angina 
 Symptom-based measure Self-reported diagnoses Symptom-based measure Self-reported diagnoses Symptom-based measure Self-reported diagnoses 
 Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 
Male 0.54
* 
[0.32,0.89] 
0.54* 
[0.32,0.90] 
0.73 
[0.31,1.71] 
0.39** 
[0.20,0.77] 
0.31*** 
[0.16,0.61] 
0.20* 
[0.055,0.70] 
0.78 
[0.60,1.00] 
0.72* 
[0.55,0.95] 
0.95 
[0.63,1.42] 
1.12 
[0.79,1.59] 
1.08 
[0.76,1.54] 
1.40 
[0.86,2.28] 
0.57 
[0.30,1.07] 
0.74 
[0.37,1.46] 
0.75 
[0.34,1.64] 
0.69 
[0.45,1.06] 
0.73 
[0.46,1.14] 
0.66 
[0.37,1.18] 
Asset 0.38
*** 
[0.23,0.62] 
 
0.51* 
[0.27,0.96] 
 
 
1.01 
[0.40,2.55] 
2.01 
[0.60,6.71] 
 
 
0.47*** 
[0.37,0.60] 
0.45*** 
[0.35,0.58] 
 
 
1.10 
[0.81,1.49] 
 
0.99 
[0.73,1.34] 
 
 
0.39** 
[0.21,0.72] 
 
0.47* 
[0.23,0.98] 
 
 
0.87 
[0.55,1.38] 
 
1.21 
[0.76,1.93] 
 
 
Education 0.89 
[0.79,1.00] 
 
 
0.91 
[0.82,1.02] 
1.08 
[0.99,1.18] 
 
 
1.16** 
[1.04,1.29] 
0.92** 
[0.86,0.98] 
 
 
0.94* 
[0.89,1.00] 
0.98 
[0.94,1.04] 
 
 
 
1.00 
[0.95,1.05] 
0.97 
[0.90,1.04] 
 
 
 
0.99 
[0.92,1.07] 
0.98 
[0.93,1.03] 
 
 
 
1.04 
[0.95,1.13] 
Hypertension 
 Criterion-based measure Self-reported diagnoses Criterion-based measure Self-reported diagnoses Criterion-based measure Self-reported diagnoses 
 Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 
Male 1.05 
[0.83,1.34] 
1.03 
[0.80,1.32] 
1.35 
[0.96,1.90] 
0.65 
[0.42,1.01] 
0.54** 
[0.34,0.86] 
0.52 
[0.26,1.03] 
1.05 
[0.90,1.23] 
1.03 
[0.88,1.21] 
1.07 
[0.85,1.36] 
0.61*** 
[0.49,0.75] 
0.56*** 
[0.44,0.70] 
0.45*** 
[0.34,0.61] 
1.29** 
[1.08,1.54] 
1.31** 
[1.08,1.59] 
1.34** 
[1.09,1.66] 
0.83 
[0.66,1.05] 
0.89 
[0.69,1.14] 
0.85 
[0.63,1.13] 
Asset 1.34
* 
[1.03,1.74] 
 
1.17 
[0.87,1.59] 
 
 
3.82*** 
[2.38,6.15] 
3.53*** 
[2.08,6.00] 
 
 
1.16 
[0.98,1.37] 
1.05 
[0.87,1.25] 
 
 
2.27*** 
[1.83,2.81] 
 
2.13*** 
[1.71,2.65] 
 
 
0.70*** 
[0.57,0.86] 
 
1.06 
[0.84,1.33] 
 
 
0.93 
[0.73,1.17] 
 
1.52** 
[1.14,2.01] 
 
 
Education 0.96 
[0.93,1.00] 
 
 
 
0.95* 
[0.91,0.99] 
1.06 
[0.97,1.15] 
 
 
1.05 
[0.96,1.16] 
0.99 
[0.96,1.02] 
 
 
1.00 
[0.97,1.03] 
1.03 
[1.00,1.07] 
 
 
 
1.09*** 
[1.05,1.12] 
0.92*** 
[0.90,0.95] 
 
 
 
1.00 
[0.96,1.03] 
0.95** 
[0.92,0.98] 
 
 
 
1.01 
[0.96,1.05] 
Asthma and chronic lung disease 
 Criterion-based measure Self-reported diagnoses Criterion-based measure Self-reported diagnoses Criterion-based measure Self-reported diagnoses 
 Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 
Male 0.80 
[0.32,1.99] 
0.79 
[0.32,1.96] 
0.66 
[0.16,2.70] 
1.08 
[0.52,2.27] 
1.09 
[0.53,2.25] 
0.89 
[0.39,2.04] 
0.87 
[0.66,1.14] 
0.81 
[0.62,1.07] 
0.68* 
[0.47,0.98] 
1.51* 
[1.09,2.09] 
1.43* 
[1.03,1.99] 
1.26 
[0.75,2.12] 
0.42*** 
[0.25,0.69] 
0.39** 
[0.22,0.69] 
0.41** 
[0.22,0.80] 
1.84 
[0.99,3.44] 
2.06* 
[1.07,3.94] 
2.43* 
[1.02,5.81] 
Asset  
1.04 
[0.54,2.03] 
0.92 
[0.54,1.56] 
 
 
0.99 
[0.59,1.64] 
0.82 
[0.45,1.48] 
 
 
0.88 
[0.66,1.16] 
0.91 
[0.67,1.24] 
 
 
1.11 
[0.74,1.65] 
 
1.03 
[0.68,1.56] 
 
 
0.65 
[0.28,1.49] 
 
0.99 
[0.54,1.80] 
 
 
0.89 
[0.37,2.15] 
 
1.00 
[0.47,2.13] 
 
 
Education 0.98 
[0.86,1.12] 
 
 
0.98 
[0.86,1.13] 
0.95 
[0.88,1.03] 
 
 
0.96 
[0.89,1.04] 
0.97 
[0.93,1.01] 
 
 
 
1.00 
[0.96,1.04] 
1.01 
[0.94,1.09] 
 
 
 
1.03 
[0.97,1.11] 
0.95 
[0.87,1.04] 
 
 
 
0.97 
[0.91,1.04] 
1.00 
[0.88,1.12] 
 
 
 
0.98 
[0.83,1.17] 
Visual impairment 
 Criterion-based measure Self-reported diagnoses Criterion-based measure Self-reported diagnoses Criterion-based measure Self-reported diagnoses 
 Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 
Male 1.15 
[0.84,1.58] 
1.10 
[0.79,1.53] 
1.39 
[0.79,2.45] 
0.58 
[0.32,1.08] 
0.49* 
[0.26,0.94] 
0.28* 
[0.093,0.82] 
0.75*** 
[0.65,0.87] 
0.62*** 
[0.52,0.74] 
0.72* 
[0.54,0.95] 
0.94 
[0.77,1.15] 
0.85 
[0.68,1.06] 
0.86 
[0.61,1.23] 
0.73** 
[0.58,0.92] 
0.74* 
[0.58,0.94] 
0.80 
[0.61,1.05] 
0.66 
[0.43,1.01] 
0.73 
[0.46,1.17] 
0.82 
[0.44,1.56] 
Asset 0.78 
[0.55,1.09] 
 
0.93 
[0.63,1.38] 
 
 
2.37** 
[1.28,4.42] 
2.63*** 
[1.48,4.68] 
 
 
0.81** 
[0.70,0.94] 
 
0.72*** 
[0.60,0.86] 
 
 
1.37** 
[1.12,1.67] 
 
1.28* 
[1.04,1.58] 
 
 
0.66** 
[0.50,0.87] 
 
0.84 
[0.64,1.11] 
 
 
0.68 
[0.40,1.14] 
 
1.14 
[0.69,1.88] 
 
 
Education 0.98 
[0.91,1.05] 
 
 
0.98 
[0.91,1.06] 
1.23** 
[1.09,1.39] 
 
 
1.25*** 
[1.10,1.43] 
0.92*** 
[0.89,0.95] 
 
 
 
0.97* 
[0.93,1.00] 
0.96* 
[0.92,1.00] 
 
 
 
1.02 
[0.97,1.06] 
1.01 
[0.96,1.05] 
 
 
 
1.03 
[0.99,1.08] 
0.93* 
[0.88,0.99] 
 
 
 
0.98 
[0.89,1.08] 
Depression 
 Symptom-based measure Self-reported diagnoses Symptom-based measure Self-reported diagnoses Symptom-based measure Self-reported diagnoses 
 Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 
Male 0.89 
[0.52,1.53] 
0.81 
[0.46,1.41] 
1.42 
[0.56,3.61] 
1.50 
[0.54,4.18] 
1.30 
[0.47,3.62] 
2.56 
[0.62,10.6] 
0.79* 
[0.63,0.99] 
0.74* 
[0.59,0.94] 
0.97 
[0.69,1.38] 
1.78*** 
[1.26,2.51] 
1.71** 
[1.22,2.39] 
1.44 
[0.89,2.33] 
1.18 
[0.54,2.61] 
1.23 
[0.56,2.70] 
1.51 
[0.63,3.62] 
0.75 
[0.15,3.84] 
0.81 
[0.18,3.78] 
0.89 
[0.22,3.58] 
Asset 1.25 
[0.65,2.43] 
1.01 
[0.53,1.91] 
 
 
2.08 
[0.51,8.55] 
2.34 
[0.91,6.00] 
 
 
0.59*** 
[0.48,0.73] 
 
0.56*** 
[0.45,0.71] 
 
 
1.15 
[0.82,1.61] 
 
1.17 
[0.81,1.68] 
 
 
0.59 
[0.24,1.47] 
 
0.48 
[0.22,1.01] 
 
 
3.10 
[0.72,13.3] 
 
2.68 
[0.35,20.6] 
 
 
Education 0.93 
[0.83,1.04] 
 
 
0.91 
[0.81,1.04] 
0.95 
[0.86,1.05] 
 
 
0.93* 
[0.87,0.99] 
0.93** 
[0.89,0.98] 
 
 
 
0.96 
[0.91,1.00] 
0.99 
[0.93,1.05] 
 
 
 
1.00 
[0.94,1.06] 
0.98 
[0.89,1.08] 
 
 
 
0.98 
[0.87,1.11] 
0.90 
[0.74,1.09] 
 
 
 
0.83 
[0.60,1.13] 
Notes: i)95% confidence intervals in brackets; ii) * p < 0.05, ** p < 0.01, *** p < 0.001; iii) dependent variable is symptom-based/criterion-based measure and self-reported diagnoses of each 
NCD, and is defined as 1 if the respondent had the NCD, and 0 if otherwise; iv) Male is dichotomous variable with female as reference category, asset is defined as the asset index of the 
household, and education is defined as years of education; v) Model 1 estimated unadjusted odds ratio by regressing each independent variable on NCD prevalence separately; Model 2 is 
adjusted for rural-urban, age, gender and asset, where Model 3 is adjusted for rural-urban, age, gender and education. Model 2 and 3 of symptom-based/criterion-based measures of each was 
also adjusted with a dichotomous variable of whether the respondent has taken medication/treatment or not.  
 
 
 
 
 
 
 
Web Appendix Table 6: Unadjusted and Adjusted Odds Ratio (with 95% CI) of self-reported diagnoses and symptoms-based/criterion-based 
measures of NCDs among adult population in South Africa, Mexico, and Russia. 
 South Africa Mexico Russia 
Angina 
 Symptom-based measure Self-reported diagnoses Symptom-based measure Self-reported diagnoses Symptom-based measure Self-reported diagnoses 
 Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 
Male 0.24
*** 
[0.11,0.52] 
0.29** 
[0.12,0.69] 
0.45 
[0.18,1.13] 
0.28** 
[0.13,0.62] 
0.28** 
[0.13,0.61] 
0.20*** 
[0.07,0.52] 
0.44* 
[0.20,0.99] 
0.49 
[0.21,1.14] 
0.43 
[0.18,1.01] 
0.29* 
[0.10,0.83] 
0.28* 
[0.10,0.79] 
0.31* 
[0.10,0.96] 
0.81 
[0.52,1.27] 
1.05 
[0.61,1.79] 
1.22 
[0.72,2.08] 
0.84 
[0.59,1.20] 
0.94 
[0.63,1.41] 
0.94 
[0.62,1.42] 
Asset 0.97 
[0.60,1.57] 
 
1.30 
[0.62,2.71] 
 
 
5.33** 
[1.58,18.0] 
 
6.23** 
[1.85,21.0] 
 
 
0.36* 
[0.15,0.87] 
 
0.30* 
[0.11,0.80] 
 
 
1.85 
[0.42,8.11] 
2.29 
[0.51,10.3] 
 
 
0.60* 
[0.40,0.90] 
 
0.94 
[0.52,1.70] 
 
 
0.69* 
[0.47,1.00] 
 
1.17 
[0.75,1.82] 
 
 
Educati
on 
0.86 
[0.72,1.03] 
 
 
 
0.93 
[0.76,1.13] 
0.93 
[0.82,1.06] 
 
 
 
0.96 
[0.84,1.11] 
0.88 
[0.77,1.01] 
 
 
 
0.88 
[0.77,1.01] 
0.87* 
[0.78,0.97] 
 
 
0.96 
[0.88,1.05] 
0.86*** 
[0.81,0.91] 
 
 
 
0.96 
[0.89,1.04] 
0.90*** 
[0.85,0.95] 
 
 
 
1.02 
[0.96,1.08] 
Hypertension 
 Criterion-based measure Self-reported diagnoses Criterion-based measure Self-reported diagnoses Criterion-based measure Self-reported diagnoses 
Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 
Male 1.33 
[0.77,2.32] 
1.44 
[0.82,2.53] 
2.11* 
[1.02,4.38] 
0.49** 
[0.32,0.76] 
0.45*** 
[0.29,0.68] 
0.35*** 
[0.20,0.58] 
1.12 
[0.65,1.92] 
1.37 
[0.79,2.40] 
1.35 
[0.75,2.43] 
0.54* 
[0.31,0.93] 
0.46** 
[0.27,0.76] 
0.45** 
[0.26,0.79] 
0.96 
[0.71,1.30] 
1.36 
[0.95,1.93] 
1.22 
[0.86,1.73] 
0.61** 
[0.44,0.83] 
0.62* 
[0.43,0.90] 
0.65* 
[0.45,0.94] 
Asset 0.88 
[0.54,1.43] 
 
0.99 
[0.63,1.56] 
 
 
1.57* 
[1.03,2.37] 
 
1.78** 
[1.22,2.60] 
 
 
0.88 
[0.47,1.64] 
 
0.80 
[0.39,1.62] 
 
 
2.04* 
[1.09,3.80] 
 
2.75** 
[1.50,5.04] 
 
 
0.46*** 
[0.31,0.67] 
 
0.50** 
[0.32,0.78] 
 
 
0.74 
[0.51,1.07] 
 
1.25 
[0.82,1.88] 
 
 
Educati
on 
0.93 
[0.86,1.00] 
 
 
 
0.97 
[0.90,1.05] 
0.90** 
[0.84,0.97] 
 
 
 
0.98 
[0.92,1.05] 
0.97 
[0.92,1.03] 
 
 
 
1.04 
[0.98,1.11] 
0.95 
[0.86,1.05] 
 
 
 
1.03 
[0.93,1.14] 
0.88*** 
[0.84,0.92] 
 
 
 
0.97 
[0.92,1.02] 
0.90*** 
[0.86,0.94] 
 
 
 
1.00 
[0.95,1.06] 
Asthma and chronic lung disease 
 Criterion-based measure Self-reported diagnoses Criterion-based measure Self-reported diagnoses Criterion-based measure Self-reported diagnoses 
 Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 
Male 1.71 
[0.66,4.40] 
1.97 
[0.78,4.96] 
0.92 
[0.26,3.25] 
0.56 
[0.29,1.11] 
0.58 
[0.30,1.14] 
0.50 
[0.22,1.13] 
3.49 
[0.37,32.8] 
3.01 
[0.39,23.5] 
3.84 
[0.41,36.0] 
0.31* 
[0.11,0.84] 
0.30* 
[0.10,0.89] 
0.30* 
[0.10,0.88] 
0.48 
[0.16,1.45] 
0.54 
[0.14,2.04] 
0.50 
[0.12,2.18] 
0.97 
[0.45,2.12] 
1.04 
[0.47,2.30] 
0.88 
[0.37,2.11] 
Asset 0.76 
[0.41,1.40] 
 
1.03 
[0.47,2.23] 
 
 
0.97 
[0.42,2.24] 
 
0.95 
[0.39,2.28] 
 
 
6.51 
[0.92,45.8] 
 
6.19 
[0.81,47.5] 
 
 
1.42 
[0.45,4.46] 
 
1.32 
[0.38,4.66] 
 
 
0.45 
[0.14,1.44] 
 
0.80 
[0.11,5.55] 
 
 
0.85 
[0.39,1.84] 
 
1.05 
[0.43,2.56] 
 
 
Educati
on 
0.71*** 
[0.64,0.78] 
 
 
 
0.78** 
[0.66,0.93] 
0.86** 
[0.76,0.96] 
 
 0.91 
[0.81,1.01] 
0.99 
[0.95,1.04] 
 
 
 
0.96 
[0.86,1.08] 
1.12 
[0.94,1.34] 
 
 1.14 
[0.98,1.33] 
0.72*** 
[0.66,0.79] 
 
 
 
0.90* 
[0.82,0.99] 
0.85*** 
[0.79,0.91] 
 
 
 0.91 
[0.83,1.00] 
Visual impairment 
 Criterion-based measure Self-reported diagnoses Criterion-based measure Self-reported diagnoses Criterion-based measure Self-reported diagnoses 
 Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 
Male 1.42 
[0.78,2.57] 
1.44 
[0.80,2.59] 
1.07 
[0.53,2.16] 
0.58 
[0.20,1.70] 
0.61 
[0.20,1.88] 
0.39 
[0.14,1.08] 
0.91 
[0.50,1.65] 
0.97 
[0.55,1.70] 
0.91 
[0.50,1.67] 
0.87 
[0.41,1.86] 
0.92 
[0.39,2.16] 
0.91 
[0.38,2.20] 
1.04 
[0.74,1.47] 
1.20 
[0.83,1.73] 
1.32 
[0.91,1.89] 
1.01 
[0.64,1.57] 
1.23 
[0.74,2.04] 
1.01 
[0.62,1.65] 
Asset 1.03 
[0.58,1.84] 
 
1.02 
[0.53,1.98] 
 
 
0.63 
[0.14,2.94] 
 
0.57 
[0.11,3.03] 
 
 
0.67 
[0.30,1.53] 
 
0.84 
[0.37,1.92] 
 
 
0.79 
[0.21,2.99] 
 
0.82 
[0.19,3.52] 
 
 
0.67* 
[0.46,0.97] 
 
0.92 
[0.59,1.45] 
 
 
0.56* 
[0.31,0.99] 
 
0.89 
[0.44,1.81] 
 
 
Educati
on 
1.06 
[0.94,1.20] 
 
 
 
1.09 
[0.96,1.23] 
0.85* 
[0.74,0.98] 
 
 
 
0.91 
[0.75,1.10] 
0.90 
[0.81,1.01] 
 
 
 
0.98 
[0.89,1.07] 
0.92 
[0.79,1.07] 
 
 
 
0.99 
[0.89,1.10] 
0.87*** 
[0.82,0.92] 
 
 
 
0.93* 
[0.89,0.98] 
0.90*** 
[0.84,0.96] 
 
 
 
1.03 
[0.96,1.10] 
Depression 
 Symptom-based measure Self-reported diagnoses Symptom-based measure Self-reported diagnoses Symptom-based measure Self-reported diagnoses 
 Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 Model 1 Model 2 Model 3 
Male 0.098
*** 
[0.03,0.29] 
0.17*** 
[0.068,0.43
] 
0.16** 
[0.048,0.55] 
0.086*** 
[0.03,0.25] 
0.085*** 
[0.03,0.25] 
0.078*** 
[0.02,0.26] 
0.16** 
[0.05,0.53] 
0.18** 
[0.060,0.55
] 
0.17** 
[0.050,0.58
] 
0.054*** 
[0.03,0.11] 
0.051*** 
[0.03,0.10] 
0.048*** 
[0.02,0.098
] 
0.75 
[0.33,1.68] 
0.87 
[0.38,2.01] 
0.65 
[0.25,1.67] 
0.53 
[0.22,1.28] 
0.54 
[0.22,1.31] 
0.56 
[0.23,1.34] 
Asset 0.67
* 
[0.46,1.00] 
 
0.56 
[0.19,1.61] 
 
 
1.33 
[0.56,3.15] 
 
1.04 
[0.38,2.86] 
 
 
1.48 
[0.54,4.07] 
 
1.53 
[0.46,5.05] 
 
 
1.22 
[0.63,2.37] 
 
1.43 
[0.63,3.28] 
 
 
0.71 
[0.35,1.43] 
 
0.86 
[0.39,1.87] 
 
 
1.38 
[0.58,3.28] 
 
1.45 
[0.61,3.48] 
 
 
Educati
on 
0.91* 
[0.84,0.98] 
 
 
 
0.87* 
[0.76,0.99] 
0.98 
[0.90,1.07] 
 
 
 
1.00 
[0.91,1.10] 
1.00 
[0.86,1.17] 
 
 
 
1.03 
[0.87,1.21] 
0.97 
[0.88,1.07] 
 
 
 
1.00 
[0.91,1.10] 
1.01 
[0.94,1.08] 
 
 
 
1.04 
[0.96,1.12] 
0.99 
[0.90,1.07] 
 
 
 
0.97 
[0.86,1.08] 
Notes: i) 95% confidence intervals in brackets; ii) * p < 0.05, ** p < 0.01, *** p < 0.001; iii) dependent variable is symptom-based/criterion-based measure and self-reported diagnoses of each 
NCD, and is defined as 1 if the respondent had the NCD, and 0 if otherwise; iv) Male is dichotomous variable with female as reference category, asset is defined as the asset index of the 
household, and education is defined as years of education; v) Model 1 estimated unadjusted odds ratio by regressing each independent variable on NCD prevalence separately; Model 2 is 
adjusted for rural-urban, age, gender and asset, where Model 3 is adjusted for rural-urban, age, gender and education. Model 2 and 3 of symptom-based/criterion-based measures of each was 
also adjusted with a dichotomous variable of whether the respondent has taken medication/treatment or not.  
  
 
 
 
 
 
Web Appendix  Table 7: Summary of the socioeconomic pattern of prevalence between self-reported diagnoses and symptoms-based/criterion-
based measures of specific NCDs in China, Ghana, India, Mexico, Russia, and South Africa 
 Angina 
 
Hypertension Asthma and lung diseases Visual impairments Depression 
 Symptoms-
based/criterio
n-based 
measures 
Self-
reported 
diagnos
es 
Symptoms-
based/criterio
n-based 
measures 
Self-
reported 
diagnos
es 
Symptoms-
based/criterio
n-based 
measures 
Self-
reported 
diagnos
es 
Symptoms-
based/criterio
n-based 
measures 
Self-
reported 
diagnos
es 
Symptoms-
based/criterio
n-based 
measures 
Self-
reported 
diagnos
es 
Concentrati
on of NCD  
among poor 
 
 
Ghana, India, 
China, Mexico, 
Russia 
 
- China, South 
Africa, Mexico, 
Russia 
-  India, China, 
South Africa,  
Russia 
Ghana, 
India, 
China, 
Mexico 
Ghana, India, 
China, Mexico, 
Russia 
Mexico, 
Russia 
 India, China, 
South Africa, 
Russia 
 
- 
Concentrati
on of NCD 
among less 
educated    
 
 
Ghana, India, 
South Africa, 
Mexico, Russia 
 
South 
Africa 
Ghana, India, 
China, South 
Africa,  Russia 
Russia India, South 
Africa , Russia 
Ghana, 
China, 
South 
Africa 
Ghana, India, 
Mexico, Russia 
South 
Africa 
 India, China, 
South Africa 
China 
Concentrati
on of  
NCD 
among rich 
 
 
 
 
 
South Africa* Ghana, 
India, 
China, 
South 
Africa, 
Mexico 
 
 
Ghana*, India* Ghana, 
India, 
China, 
South 
Africa, 
Mexico, 
Russia 
Ghana,  Mexico South 
Africa, 
Russia 
South Africa* Ghana, 
India, 
China, 
South 
Africa 
Ghana*, 
Mexico 
Ghana, 
India, 
China, 
South 
Africa, 
Mexico, 
Russia 
 
Concentrati
on of NCD 
among 
more 
educated   
China* Ghana, 
India, 
China, 
Mexico, 
Russia 
Mexico Ghana, 
India, 
China, 
South 
Africa 
Ghana, China, 
South Africa, 
Mexico 
India, 
Mexico 
China*, South 
Africa 
Ghana, 
India, 
China, 
Mexico, 
Russia 
Ghana*, 
Mexico*, 
Russia 
Ghana, 
India, 
South 
Africa, 
Mexico, 
Russia 
* With trends in attenuation (turned to less positive) in the magnitude of inequality by detecting more prevalence cases from lower SES 
 
 
Web Appendix Table 8: Age-adjusted prevalence rate (in %, with 95% CI) of NCDs among men and women, measured through self-reported 
diagnoses and symptoms-based/criterion-based measure, among adult population in China, Ghana, India, Mexico, Russia, and South Africa 
 Angina Hypertension Asthma and chronic lung 
diseases 
Visual impairment Depression 
 Symptoms-
based 
measure 
Self-reported 
diagnoses 
Criterion-
based measure 
Self-reported 
diagnoses 
Criterion-
based measure 
Self-reported 
diagnoses 
Criterion-
based measure 
Self-reported 
diagnoses 
Symptoms-
based measure 
Self-reported 
diagnoses 
Ghana 
Men 2.7[1.7; 3.7] 0.9[0.6; 1.3] 43.8[40.1; 47.5] 6.2[4.2; 8.1] 1.5[0.9; 2.1] 1.9[1.0; 2.9] 15.3[12.8; 17.8] 1.6[1.1; 2.1] 3.8[2.4; 5.3] 0.9[0.1; 1.6] 
Women 5.0[3.6; 6.4] 2.5[1.2; 3.9] 42.9[38.8; 47.0] 9.4[7.1; 11.6] 1.7[0.5; 2.8] 2.0[1.1; 2.9] 12.5[10.3; 14.7] 2.5[1.6; 3.3] 4.7[3.3; 6.2] 0.6[0.4; 0.8] 
All Sample 3.9[3.0;4.8] 1.7[1.0;2.3] 42.2[39.4;45.0] 7.4[6.0;8.8] 1.4[0.8;2.1] 2.2[1.5;3.0] 13.9[12.2;15.7] 2.3[1.6;2.9] 4.2[3.2;5.2] 0.8[0.3;1.2] 
India 
Men 6.2[4.8; 7.5] 3.2[2.4; 4.0] 19.3[17.3; 21.4] 7.0[5.8; 8.2] 5.0[3.9; 6.1] 4.5[3.6; 5.5] 14.3[13.0; 15.7] 5.7[4.9; 6.5] 7.5[6.1; 8.8] 4.1[3.2; 5.1] 
Women 8.2[7.3; 9.1] 3.0[2.5; 3.6] 19.5[18.1; 20.8] 12.4[11.3; 13.5] 5.6[4.8; 6.4] 3.2[2.6; 3.9] 19.6[18.4; 20.8] 6.5[5.9; 7.2] 10.1[9.1; 11.0] 2.6[1.9; 3.2] 
All Sample 7.0[6.2;7.8] 3.1[2.6;3.6] 19.1[17.9;20.3] 9.4[8.6;10.2] 5.2[4.6;5.9] 5.8[5.1;6.6] 16.7[15.8;17.7] 6.1[5.5;6.6] 8.5[7.7;9.3] 3.4[2.8;3.9] 
China 
Men 1.0[0.6; 1.4] 3.2[2.1; 4.4] 41.1[38.1; 44.1] 10.4[8.9; 11.8] 0.9[0.6; 1.2] 1.5[0.8; 2.2] 13.2[11.4; 15.1] 2.3[1.4; 3.1] 1.1[0.4; 1.8] 0.3[-0.1; 0.7] 
Women 1.9[1.2; 2.6] 4.3[3.5; 5.2] 35.0[32.5; 37.4] 12.2[10.8; 13.7] 2.0[1.3; 2.7] 0.8[0.5; 1.1] 16.7[14.8; 18.7] 3.0[2.6; 3.3] 0.9[0.5; 1.3] 0.4[0.0; 0.9] 
All Sample 1.4[1.0;1.8] 3.8[3.1;4.5] 38.0[36.0;40.0] 11.3[10.2;12.4] 1.4[1.1;1.7] 4.2[3.5;4.9] 14.8[13.5;16.2] 2.6[2.2;3.1] 1.0[0.6;1.5] 0.4[0.1;0.7] 
South Africa 
Men 0.7[0.4; 1.0] 1.4[0.7; 2.1] 55.4[48.5; 62.3] 7.4[6.1; 8.6] 1.0[0.4; 1.6] 1.8[1.0; 2.5] 22.4[17.3; 27.5] 1.8[0.5; 3.1] 0.9[0.5; 1.4] 0.9[0.4; 1.4] 
Women 2.2[1.1; 3.3] 3.9[1.2; 6.7] 46.7[41.3; 52.1] 11.8[9.6; 14.0] 0.6[0.3; 0.9] 2.8[1.6; 4.1] 18.4[14.8; 21.9] 3.1[1.0; 5.2] 7.9[4.1; 11.6] 9.1[4.9; 13.2] 
All Sample 1.6[0.8;2.3] 2.7[1.4;3.9] 49.1[43.5;54.7] 9.9[8.5;11.4] 0.8[0.5;1.2] 4.2[2.2;6.2] 21.6[17.5;25.6] 2.2[1.0;3.3] 4.2[1.3;7.0] 4.6[1.6;7.5] 
Mexico           
Men 4.0[2.0; 5.9] 0.5[0.2; 0.7] 33.3[27.1; 39.4] 10.0[7.7; 12.4] 3.8[-0.6; 8.3] 0.7[0.2; 1.2] 22.9[18.7; 27.2] 4.1[1.9; 6.3] 1.8[0.3; 3.3] 1.4[0.7; 2.0] 
Women 8.2[5.7; 10.8] 1.9[0.5; 3.3] 27.3[22.6; 32.1] 15.7[12.5; 18.9] 0.5[-0.1; 1.0] 2.0[1.1; 2.9] 24.5[20.5; 28.6] 4.0[2.6; 5.4] 9.7[6.9; 12.6] 18.4[14.7; 22.1] 
All Sample 6.5[4.5;8.5] 1.1[0.4;1.8] 27.7[23.5;31.8] 13.2[11.0;15.4] 1.2[-0.6;3.1] 6.6[2.4;10.7] 24.3[20.9;27.7] 4.0[2.8;5.1] 6.3[4.3;8.3] 10.1[7.8;12.5] 
Russia 
Men 14.0[10.8;17.2] 23.1[19.7; 26.5] 42.2[38.2; 46.2] 31.7[27.6; 35.8] 0.3[0.0; 0.6] 4.7[2.6; 6.8] 23.7[20.6; 26.9] 10.3[7.9; 12.8] 4.4[2.1; 6.7] 2.4[0.9; 3.9] 
Women 16.7[14.5;18.9] 24.8[22.0; 27.7] 41.8[38.8; 44.9] 41.0[37.9; 44.2] 0.3[0.1; 0.5] 5.5[3.5; 7.5] 23.1[20.4; 25.8] 9.4[7.4; 11.4] 5.2[3.6; 6.9] 4.7[2.9; 6.6] 
All Sample 15.7[13.5;17.9] 23.8[21.2;26.3] 41.9[39.1;44.6] 36.7[33.9;39.4] 0.3[0.1;0.4] 15.0[12.8;17.2] 24.3[21.9;26.8] 9.6[8.1;11.2] 4.8[3.3;6.3] 3.9[2.4;5.3] 
Source: WHO SAGE survey, 2007-10 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Web Appendix Table 9: Age-adjusted wealth-related and education-related concentration index (in %, with 95% CI) of disease, measured 
through self-reported diagnoses and symptoms-based/criterion-based measures, among adult men and women in China, Ghana, India, Mexico, 
Russia, and South Africa 
 Wealth-related concentration index Education-related concentration index 
 Men Women Men Women 
 Symptoms-
based/criterion-
based measure 
Self-reported 
diagnoses 
Symptoms-
based/criterion-
based measure 
Self-reported 
diagnoses 
Symptoms-
based/criterion-
based measure 
Self-reported 
diagnoses 
Symptoms-
based/criterion-
based measure 
Self-reported 
diagnoses 
Angina 
Ghana -0.20[-0.22;-0.18] 0.09[0.07; 0.10] -0.19[-0.22;-0.17] 0.06[0.03; 0.10] 0.02[0.00;0.03] 0.06[0.02; 0.10] -0.26[-0.28;-0.24] 0.54[0.50; 0.58] 
India -0.24[-0.26;-0.23] 0.05[0.04; 0.05] -0.10[-0.11;-0.10] -0.02[-0.02; -0.02] -0.11[-0.12;-0.10] 0.00[-0.01; 0.01] 0.00[0.00;0.00] -0.03[-0.03; -0.03] 
China -0.06[-0.06;-0.05] 0.16[0.15; 0.16] -0.11[-0.12;-0.11] 0.00[0.00; 0.01] 0.01[-0.01;0.03] 0.03[0.01; 0.05] 0.03[0.02;0.04] 0.19[0.18; 0.20] 
South Africa -0.32[-0.37;-0.26] 0.42[0.34; 0.50] 0.07[0.01;0.14] 0.37[0.30; 0.45] -0.09[-0.14;-0.05] -0.01[-0.03; 0.02] -0.24[-0.30;-0.18] -0.14[-0.21; -0.07] 
Mexico -0.48[-0.57;-0.39] 0.21[0.13; 0.28] -0.10[-0.14;-0.05] 0.18[0.16; 0.21] -0.22[-0.27;-0.17] 0.24[0.08; 0.39] -0.01[-0.06;0.03] 0.04[-0.03; 0.11] 
Russia 0.00[-0.01;0.01] -0.01[-0.03; 0.00] -0.03[-0.03;-0.02] 0.00[0.00; 0.00] -0.12[-0.15;-0.09] 0.08[0.06; 0.09] 0.00[-0.01;0.01] 0.02[0.02; 0.03] 
Hypertension 
Ghana 0.01[0.01;0.02] 0.45[0.42; 0.48] 0.05[0.04;0.06] 0.25[0.23; 0.28] 0.00[0.00;0.01] 0.12[0.11; 0.14] -0.08[-0.09;-0.07] 0.10[0.09; 0.12] 
India 0.06[0.05;0.06] 0.21[0.20; 0.23] -0.01[-0.01;-0.01] 0.17[0.17; 0.18] 0.01[0.00;0.01] 0.17[0.16; 0.18] -0.02[-0.02;-0.02] 0.02[0.01; 0.02] 
China 0.00[0.00;0.00] 0.12[0.12; 0.13] -0.04[-0.04;-0.03] 0.06[0.06; 0.06] -0.02[-0.02;-0.01] 0.11[0.10; 0.12] -0.07[-0.07;-0.07] 0.01[0.01; 0.01] 
South Africa 0.02[0.01;0.04] 0.11[0.08; 0.15] -0.04[-0.05;-0.03] 0.18[0.15; 0.21] 0.03[0.00;0.06] -0.10[-0.15; -0.05] -0.06[-0.08;-0.05] 0.05[0.00; 0.11] 
Mexico -0.01[-0.03;0.00] 0.18[0.13; 0.23] -0.01[-0.01;0.00] 0.13[0.09; 0.16] 0.10[0.07;0.13] 0.25[0.18; 0.32] 0.10[0.07;0.13] -0.13[-0.14; -0.11] 
Russia -0.11[-0.13;-0.10] 0.08[0.07; 0.08] -0.02[-0.03;-0.02] 0.02[0.01; 0.02] -0.01[-0.01;0.00] 0.02[0.01; 0.03] -0.03[-0.04;-0.03] -0.06[-0.07; -0.05] 
Asthma and chronic lung disease 
Ghana -0.11[-0.13;-0.09] 0.00[-0.02; 0.02] 0.22[0.19;0.25] 0.04[0.02; 0.06] -0.19[-0.21;-0.17] -0.05[-0.08; -0.03] 0.40[0.36;0.43] -0.30[-0.33; -0.28] 
India -0.06[-0.06;-0.05] 0.02[0.01; 0.02] -0.02[-0.03;-0.02] 0.00[-0.01; 0.00] 0.03[0.01;0.04] 0.06[0.05; 0.06] 0.04[0.03;0.04] -0.02[-0.02; -0.02] 
China -0.27[-0.28;-0.26] 0.26[0.24; 0.28] 0.06[0.06;0.07] -0.23[-0.24; -0.22] 0.07[0.04;0.09] -0.15[-0.19; -0.11] 0.01[0.00;0.01] 0.03[0.01; 0.05] 
South Africa -0.08[-0.11;-0.05] -0.22[-0.29; -0.15] -0.15[-0.22;-0.08] 0.06[0.03; 0.08] 0.13[-0.17;0.43] -0.13[-0.17; -0.09] -0.24[-0.34;-0.15] -0.17[-0.24; -0.10] 
Mexico 0.77[0.65;0.89] -0.28[-0.35; -0.21] -0.22[-0.28;-0.16] 0.17[0.13; 0.21] 0.12[-0.03;0.27] 0.09[-0.04; 0.21] 0.26[0.20;0.33] 0.18[0.12; 0.24] 
Russia -0.22[-0.26;-0.19] -0.16[-0.19; -0.12] -0.11[-0.15;-0.07] 0.09[0.07; 0.12] -0.43[-0.49;-0.38] 0.15[0.09; 0.21] -0.30[-0.34;-0.26] -0.10[-0.14; -0.06] 
Visual impairment 
Ghana -0.06[-0.06;-0.05] -0.03[-0.04; -0.03] -0.07[-0.08;-0.06] 0.41[0.39; 0.44] -0.06[-0.07;-0.05] 0.09[0.07; 0.11] 0.00[-0.01;0.02] 0.38[0.36; 0.41] 
India -0.05[-0.06;-0.05] 0.07[0.06; 0.07] -0.06[-0.07;-0.06] 0.07[0.07; 0.08] -0.05[-0.05;-0.04] 0.07[0.07; 0.07] -0.05[-0.06;-0.05] -0.05[-0.05; -0.05] 
China -0.04[-0.04;-0.03] 0.04[0.02; 0.06] 0.01[0.00;0.01] 0.05[0.05; 0.05] 0.14[0.12;0.16] 0.20[0.18; 0.22] 0.08[0.07;0.09] 0.08[0.07; 0.09] 
South Africa -0.09[-0.10;-0.07] -0.28[-0.36; -0.21] 0.18[0.14;0.23] 0.02[-0.03; 0.07] 0.00[-0.07;0.06] -0.05[-0.09; -0.01] 0.08[0.06;0.11] -0.27[-0.31; -0.23] 
Mexico -0.17[-0.24;-0.10] -0.33[-0.41; -0.25] -0.06[-0.08;-0.05] 0.10[0.07; 0.14] -0.12[-0.17;-0.08] -0.02[-0.10; 0.07] -0.04[-0.06;-0.02] 0.16[0.11; 0.21] 
Russia -0.05[-0.07;-0.03] -0.12[-0.13; -0.11] -0.03[-0.04;-0.02] -0.02[-0.03; -0.02] -0.09[-0.10;-0.07] 0.24[0.22; 0.27] 0.01[0.00;0.02] -0.18[-0.20; -0.17] 
Depression 
Ghana 0.12[0.10;0.15] 0.35[0.31; 0.39] -0.05[-0.06;-0.04] 0.04[0.03; 0.05] -0.05[-0.08;-0.03] 0.14[0.10; 0.17] 0.08[0.07;0.08] -0.22[-0.24; -0.20] 
India -0.18[-0.19;-0.17] 0.11[0.10; 0.12] -0.09[-0.09;-0.08] -0.02[-0.03; -0.02] -0.10[-0.11;-0.09] -0.02[-0.03; -0.01] 0.05[0.04;0.05] -0.06[-0.07; -0.06] 
China 0.02[0.00;0.05] 0.54[0.51; 0.56] -0.28[-0.30;-0.27] 0.03[0.01; 0.05] 0.11[0.09;0.14] 0.40[0.37; 0.43] -0.03[-0.05;-0.02] -0.32[-0.34; -0.31] 
South Africa 0.06[-0.02;0.15] 0.28[0.20; 0.36] -0.24[-0.34;-0.15] -0.01[-0.07; 0.05] -0.07[-0.12;-0.03] 0.03[-0.02; 0.08] -0.24[-0.31;-0.17] 0.05[-0.03; 0.13] 
Mexico 0.36[0.30;0.42] -0.09[-0.15; -0.04] -0.02[-0.07;0.04] 0.08[0.05; 0.12] 0.44[0.35;0.54] -0.05[-0.11; 0.00] 0.05[0.02;0.08] 0.13[0.09; 0.18] 
Russia 0.02[-0.04;0.07] 0.29[0.26; 0.33] 0.01[0.00;0.03] 0.07[0.06; 0.08] 0.22[0.16;0.28] -0.22[-0.26; -0.19] 0.08[0.07;0.09] 0.18[0.15; 0.20] 
Notes: i. Source: WHO SAGE survey, 2007-10; ii. Negative values indicate concentration of disease among lower SES, and positive values indicate concentration among 
higher SES. The symptom-based/criterion-based measures of each NCD was adjusted with age, and a dichotomous variable of whether the respondent has taken medication/treatment or not. 
 
 
 
